BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20601192)

  • 1. Mitochondrially targeted anti-cancer agents.
    Biasutto L; Dong LF; Zoratti M; Neuzil J
    Mitochondrion; 2010 Nov; 10(6):670-81. PubMed ID: 20601192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting mitochondrial apoptosis for the treatment of cancer.
    Fulda S
    Mitochondrion; 2010 Nov; 10(6):598-603. PubMed ID: 20519148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria.
    Neuzil J; Dong LF; Ramanathapuram L; Hahn T; Chladova M; Wang XF; Zobalova R; Prochazka L; Gold M; Freeman R; Turanek J; Akporiaye ET; Dyason JC; Ralph SJ
    Mol Aspects Med; 2007; 28(5-6):607-45. PubMed ID: 17499351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of mitocans, anti-cancer drugs acting on mitochondria.
    Neuzil J; Dong LF; Rohlena J; Truksa J; Ralph SJ
    Mitochondrion; 2013 May; 13(3):199-208. PubMed ID: 22846431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria as targets for cancer therapy.
    Ralph SJ; Neuzil J
    Mol Nutr Food Res; 2009 Jan; 53(1):9-28. PubMed ID: 19123183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer drugs targeting the mitochondrial electron transport chain.
    Rohlena J; Dong LF; Ralph SJ; Neuzil J
    Antioxid Redox Signal; 2011 Dec; 15(12):2951-74. PubMed ID: 21777145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Moreno-Sánchez R
    Mol Aspects Med; 2010 Feb; 31(1):29-59. PubMed ID: 20026172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent.
    Neuzil J; Tomasetti M; Zhao Y; Dong LF; Birringer M; Wang XF; Low P; Wu K; Salvatore BA; Ralph SJ
    Mol Pharmacol; 2007 May; 71(5):1185-99. PubMed ID: 17220355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins.
    Neuzil J; Wang XF; Dong LF; Low P; Ralph SJ
    FEBS Lett; 2006 Oct; 580(22):5125-9. PubMed ID: 16979626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria as therapeutic targets for the treatment of malignant disease.
    Fulda S; Kroemer G
    Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria as targets for established and novel anti-cancer agents.
    Grad JM; Cepero E; Boise LH
    Drug Resist Updat; 2001 Apr; 4(2):85-91. PubMed ID: 11512525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria: A novel target for the chemoprevention of cancer.
    Hail N
    Apoptosis; 2005 Aug; 10(4):687-705. PubMed ID: 16133861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.
    Ralph SJ; Low P; Dong L; Lawen A; Neuzil J
    Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mitochondrial permeability in cancer drug development.
    Berridge MV; Herst PM; Lawen A
    Mol Nutr Food Res; 2009 Jan; 53(1):76-86. PubMed ID: 19035550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New cytotoxic rosamine derivatives selectively accumulate in the mitochondria of cancer cells.
    Lim SH; Wu L; Burgess K; Lee HB
    Anticancer Drugs; 2009 Jul; 20(6):461-8. PubMed ID: 19387338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain.
    Joshi B; Li L; Taffe BG; Zhu Z; Wahl S; Tian H; Ben-Josef E; Taylor JD; Porter AT; Tang DG
    Cancer Res; 1999 Sep; 59(17):4343-55. PubMed ID: 10485482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mitochondrially targeted anticancer agents on mitochondrial (super)complexes.
    Vondrusova M; Bezawork-Geleta A; Sachaphibulkij K; Truksa J; Neuzil J
    Methods Mol Biol; 2015; 1265():195-208. PubMed ID: 25634277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.